Physician profile
Jason Taylor
NPI 1235136532
$191.38
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.74 · 2020: $51.95 · 2021: $36.26 · 2022: $74.43.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $49.87 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $30.89 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.44 | 2022 | |
| Akebia Therapeutics INC | $19.36 | 2021 | |
| Opko Pharmaceuticals, LLC | $16.90 | 2021 | |
| Genentech USA, INC. | $13.37 | 2019 | |
| Vifor Pharma, INC. | $12.14 | 2022 | |
| Abbott Laboratories | $11.71 | 2022 | |
| Fresenius USA Marketing, INC. | $11.70 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.